Tumor-associated trypsin inhibitor

被引：0
|
作者：
Stenman, UH [1 ]
机构：
[1] Univ Helsinki, Cent Hosp, Dept Clin Chem, Biomedicum, FIN-00029 Helsinki, Finland
来源：
CLINICAL CHEMISTRY | 2002年 / 48卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Tumor-associated trypsin inhibitor (TATI) is a low-molecular-weight (6 kDa) trypsin inhibitor that has been used as a marker for ovarian cancer. It is also expressed together with tumor-associated trypsin by many other tumors, and increased serum concentrations of TATI occur in connection with these. TATI is a prognostic marker for ovarian, bladder, and kidney cancer, which may be associated with the participation of trypsin in protease cascades contributing to tumor invasiveness. (C) 2002 American Association for Clinical Chemistry.
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [21] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN OVARIAN-CANCER
    HALILA, H
    LEHTOVIRTA, P
    STENMAN, UH
    BRITISH JOURNAL OF CANCER, 1988, 57 (03) : 304 - 307
  • [22] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) AS TUMOR-MARKER IN GYNECOLOGICAL MALIGNANCIES
    MEDL, M
    OGRIS, E
    FUCHS, G
    LEODOLTER, S
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 84 - 85
  • [23] Role of the tumor-associated trypsin inhibitor SPINK1 in cancer development
    Stenman, Ulf-Hakan
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (04) : 628 - 629
  • [24] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN THE DIAGNOSIS OF LUNG-CANCER
    PECCHIO, F
    RAPELLINO, M
    BALDI, S
    CASALI, V
    LIBERTUCCI, D
    CONI, F
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 63 - 64
  • [25] TATI (TUMOR-ASSOCIATED TRYPSIN-INHIBITOR) AS A MARKER OF OVARIAN-CANCER
    MEDL, M
    OGRIS, E
    PETERSENGL, C
    LEODOLTER, S
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 1051 - 1054
  • [26] Differential expression of trypsinogen and tumor-associated trypsin inhibitor (TATI) in bladder cancer
    Hotakainen, K
    Bjartell, A
    Sankila, A
    Järvinen, R
    Paju, A
    Rintala, E
    Haglund, C
    Stenman, UH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2006, 28 (01) : 95 - 101
  • [27] HIGH-CONCENTRATIONS OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR IN HEMODIALYZED PATIENTS
    BANFI, G
    MURONE, M
    SLAVIERO, G
    CLINICAL CHEMISTRY, 1988, 34 (01) : 174 - 175
  • [28] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR AND CANCER ANTIGEN 125 IN PELVIC MASSES
    MOGENSEN, O
    MOGENSEN, B
    JAKOBSEN, A
    GYNECOLOGIC ONCOLOGY, 1990, 38 (02) : 170 - 174
  • [29] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR, TATI - CLINICAL USE AND BIOLOGICAL FUNCTION
    STENMAN, UH
    KOIVUNEN, E
    ITKONEN, O
    TURPEINEN, U
    HALILA, H
    HUHTALA, ML
    ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1989, 78 (01) : 77 - 82
  • [30] TUMOR-ASSOCIATED TRYPSIN-INHIBITOR (TATI) IN BENIGN AND MALIGNANT GASTRIC DISEASE
    TORICAGUENA, AL
    VALLEJO, AL
    MERRUURRUTIA, MJD
    ESCUDERO, JFL
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1991, 51 : 59 - 62
12345